312 related articles for article (PubMed ID: 10070903)
1. Apoptotic activity is increased in parallel with the metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium.
Törmänen U; Nuorva K; Soini Y; Pääkkö P
Br J Cancer; 1999 Feb; 79(5-6):996-1002. PubMed ID: 10070903
[TBL] [Abstract][Full Text] [Related]
2. P53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma.
Boers JE; ten Velde GP; Thunnissen FB
Am J Respir Crit Care Med; 1996 Jan; 153(1):411-6. PubMed ID: 8542151
[TBL] [Abstract][Full Text] [Related]
3. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia.
Izawa H; Yonemitsu N; Shin T; Sugihara H
Auris Nasus Larynx; 1999 Jul; 26(3):317-30. PubMed ID: 10419041
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
5. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer.
Jeanmart M; Lantuejoul S; Fievet F; Moro D; Sturm N; Brambilla C; Brambilla E
Clin Cancer Res; 2003 Jun; 9(6):2195-203. PubMed ID: 12796386
[TBL] [Abstract][Full Text] [Related]
6. Expression of Bcl-2, Bax, and p53 proteins in carcinogenesis of squamous cell lung cancer.
Chen Y; Sato M; Fujimura S; Endo C; Sakurada A; Aikawa H; Takahashi H; Tanita T; Kondo T; Saito Y; Sagawa M
Anticancer Res; 1999; 19(2B):1351-6. PubMed ID: 10365105
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of squamous cell lung carcinoma is associated with the co-presence of reactive lesions in tumor-adjacent bronchial epithelium.
Pankova OV; Denisov EV; Ponomaryova AA; Gerashchenko TS; Tuzikov SA; Perelmuter VM
Tumour Biol; 2016 Mar; 37(3):3599-607. PubMed ID: 26456960
[TBL] [Abstract][Full Text] [Related]
8. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.
Borner MM; Brousset P; Pfanner-Meyer B; Bacchi M; Vonlanthen S; Hotz MA; Altermatt HJ; Schlaifer D; Reed JC; Betticher DC
Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
Xie X; Clausen OP; De Angelis P; Boysen M
Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
[TBL] [Abstract][Full Text] [Related]
10. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
[TBL] [Abstract][Full Text] [Related]
11. [Expression of apoptosis-related protein in epithelial dysplasia and squamous cell carcinoma].
Guan W; Yu S; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):65-8. PubMed ID: 11955367
[TBL] [Abstract][Full Text] [Related]
12. Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung.
Eerola AK; Ruokolainen H; Soini Y; Raunio H; Pääkkö P
Pathol Oncol Res; 1999; 5(3):179-86. PubMed ID: 10491014
[TBL] [Abstract][Full Text] [Related]
13. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
Torzewski M; Sarbia M; Heep H; Dutkowski P; Willers R; Gabbert HE
Clin Cancer Res; 1998 Mar; 4(3):577-83. PubMed ID: 9533524
[TBL] [Abstract][Full Text] [Related]
14. Distribution of proliferating-cell nuclear antigen and epidermal growth factor receptor in intraepithelial squamous cell lesions of human bronchus.
Yoneda K
Mod Pathol; 1994 May; 7(4):480-6. PubMed ID: 7915034
[TBL] [Abstract][Full Text] [Related]
15. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
16. Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity.
Laitinen KL; Soini Y; Mattila J; Pääkkö P
Cancer; 2000 Apr; 88(7):1590-8. PubMed ID: 10738217
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia.
Sousa FA; Paradella TC; Carvalho YR; Rosa LE
J Oral Sci; 2009 Mar; 51(1):117-21. PubMed ID: 19325208
[TBL] [Abstract][Full Text] [Related]
18. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
19. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression.
Fontanini G; Vignati S; Bigini D; Merlo GR; Ribecchini A; Angeletti CA; Basolo F; Pingitore R; Bevilacqua G
J Pathol; 1994 Sep; 174(1):23-31. PubMed ID: 7965400
[TBL] [Abstract][Full Text] [Related]
20. Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas.
Walker C; Robertson L; Myskow M; Dixon G
Br J Cancer; 1995 Jul; 72(1):164-9. PubMed ID: 7599047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
